Efficacy and toxicity of high‐risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Efficacy and toxicity of high‐risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Published:2021-10-14 Issue:2 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Binsbergen Annelien L.¹^ORCID,Haas Valérie¹^ORCID,Velden Vincent H.J.²,Groot‐Kruseman Hester A.¹³,Fiocco Marta F.¹⁴,Pieters Rob¹

Affiliation:

1. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

2. Department of Immunology, Erasmus MC University Medical Centre Rotterdam Rotterdam The Netherlands

3. Dutch Childhood Oncology Group (DCOG) Utrecht The Netherlands

4. Leiden University, Mathematical Institute The Netherlands

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29387

Reference37 articles.

1. Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

2. Improving outcomes for high-risk ALL: Translating new discoveries into clinical care

3. Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group

4. A prospective evaluation of minimal residual disease as risk stratification for CCLG‐ALL‐2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia;Hu YX;Eur Rev Med Pharmacol Sci,2016

5. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia;Best Practice & Research Clinical Haematology;2023-09

2. Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups;Journal of Clinical Oncology;2023-09-01

3. Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro;Pharmaceutics;2021-12-16